• Assess optimal management strategies for moderate hidradenitis suppurativa (HS) through interactive case-based discussions. • Understand the current treatment landscape for HS, focusing on the role of biologic therapy for moderate disease, and identify potential barriers for treatment initiation. • Highlight the importance of early treatment initiation in moderate HS to improve patient outcomes. • Explore the utility of ultrasound to aid in diagnosis and management of HS and navigate how ultrasound utilization might integrate into clinical practice.